Agoracom Blog Home

Author Archive

$APPB Applied Biosciences Launches Expanded Pet Line HerbalPet

Posted by AGORACOM at 9:12 AM on Monday, October 22nd, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

  • Expanded its product line and launched a hemp-derived CBD product pet line under the HerbalPet brand.
  • The products will be sold on herbalpet new website (www.herbalpet.com) and in select locations in the U.S
  • The CBD chews contain several important ingredients that promote good health.

LOS ANGELES, Oct. 22, 2018 (GLOBE NEWSWIRE) — Applied Biosciences Corp. (OTCQB: APPB) a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has expanded its product line and launched a hemp-derived CBD product pet line under the HerbalPet brand. The products will be sold on herbalpet new website (www.herbalpet.com) and in select locations in the U.S

Although the health benefits of CBD are becoming well known, one of the challenges of working with CBD is its bitter after taste. We commonly hear this feedback in humans and the bitterness is also true for pets. Aromas from CBD are strong and to a dog that level of concentration can be displeasing. To overcome this issue, we specifically formulated the product line with natural, high protein, human grade chicken meat – our number 1 ingredient – that dog’s love.

In addition to CBD, these chews contain several important ingredients that promote good health. In the calming support chew, consists of super foods (sweet potato and turmeric) as well as antioxidants (organic chamomile) and a natural amino acid (L-Theanine). The mobility support chew also has bone broth, glucosamine, chondroitin for bone health. It is also grain-free. Importantly, these products contain no synthetic preservatives, no fillers, no Genetically Engineered Ingredients (GMO) and no animal feed ingredients.

“Remedi continues to be at the forefront of the cannabinoid market, first using organically grown plants, without pesticides or herbicides as our main ingredient and now quickly and easily providing consumers with a variety of tinctures, topical creams and alternatives to the growing demand of this space. As Applied BioSciences continues to launch our product lines in select specialty and retail stores, people will also be able to visit remedishop.com to find a holistic health and wellness alternatives that best suit their lifestyle.” commented Chris Bridges, President of Applied BioSciences Corp.

Applied BioSciences products are USDA NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC-free. The products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact
Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com
Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

$BOB.ca Bougainville Ventures to Purchase Additional Property in Washington State $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM at 1:07 PM on Thursday, October 18th, 2018
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564641/hub/681747-5720_copy_2.jpg
  •  Entered into an agreement with Green Venture Capital Corp., to purchase the balance of a 4 acre property in Oroville, Washington.
  • Future plans for the property include multi-tenant greenhouse structures.
  • A report by the Rand organization suggests that there are currently up to 650,000 recreational marijuana users in Washington State, worth approximately $1.25 – $1.5 Billion USD in annual sales.

 Vancouver, BC, Canada – October 17, 2018, BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) (“Bougainville” or the “Company”) is pleased to announce it has entered into an agreement with Green Venture Capital Corp., to purchase the balance of a 4 acre property in Oroville, Washington.

The Company currently owns a one acre parcel of land that is occupied by a Tier -3, I-502 tenant. This transaction will add another 3 acres to the Oroville Campus. Once this transaction is completed the Company will have purchased the 4 acre parcel of land in Whatcom County, Washington State for a total purchase price of $350,000.00 USD. The Company now has up to 30 days to complete its due diligence. During this due diligence period the Company will work with its architect to develop future plans for the property that will include multi-tenant greenhouse structures.

The property meets all the Company’s criteria for its planned expansion into Washington State on it Oroville Campus. The property is permitted for both agricultural and light industrial production and processing uses, and currently contains two buildings totaling 1,700 sq. ft. and a 1,000 sq. ft. workshop/garage with sufficient room for expansion.
Andy Jagpal, President of Bougainville, commented that, “The addition of this property in Washington State will help the Company achieve its strategic goals and objectives to facilitate expansion of its Oroville Campus.”

About the Washington I-502 Marijuana Market In November 2012, the Washington State Liquor Control Board (WSLCB) passed Initiative 502 (I-502) pursuant to a vote by the people of the State of Washington. I-502 authorized the WSLCB to regulate and tax recreational marijuana products for persons over twenty-one years of age and thereby created a new industry for growing, processing and selling of Washington State-regulated recreational marijuana products. A recent WSLCB commissioned report by the Rand organization suggests that there are currently up to 650,000 recreational marijuana users in Washington State, worth approximately $1.25 – $1.5 Billion USD in annual sales.

About Bougainville Ventures, Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost. Bougainville has 30,000 sq.ft., in near production in Oroville, WA.
For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420

CLIENT FEATURE: AppliedBiosciences: Diversified in Multiple Areas of Hemp and CBD Industry $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM at 9:03 AM on Thursday, October 18th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

Why AppliedBiosciences?

    • Diversified company focused on multiple areas of the Hemp and CBD Industry
    • Focused on opportunities in the recreational, health and wellness, nutraceutical and media industries
    • Several Strategic Partnerships in place

Multiple Product Lines:

Hub On AGORACOM

FULL DISCLOSURE: AppliedBiosciences is an advertising client of AGORA Internet Relations Corp.

VIDEO: Our Interview With Co-CEO Francis Dube From The Global Graphene Expo. Must Watch Interview!

Posted by AGORACOM at 12:17 PM on Wednesday, October 17th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564424/hub/ZENYATTA_HUB.jpg

I’m very happy to have conducted my first interview with Zenyatta (Soon To Be Zen Graphene Solutions) Chairman and Co-CEO, Dr. Francis Dube. My thrill is two-fold:

1] Francis started out as an AGORACOM member and rose to the highest possible ranking on the site by providing great, intelligent conversation, analysis and information to his fellow members and shareholders. Now, he has transitioned from AGORACOM to the C-Suite of an actual public company and we couldn’t be more proud of both him and the platform for helping make this happen.

2] Francis has teamed up with Co-CEO, Don Bubar, who was one of our first clients many years ago before he too graduated Avalon to the NYSE, where the stock hit a high of ~ $10.00. Don is one of the top 5 people I have met in this industry over the past 20 years and a very well respected member of the mining industry. Their collaboration and complementary skill sets will be of great value to Zenyatta for many years to come.

On that note, this is why our first interview with Francis is a great one. The company is moving forward with great tangible steps, including the company’s most recent press releases that were well timed to coincide with the company’s presentation and exhibit at the Global Graphene Expo in Austin, Texas this week.

Taking the time to speak to his shareholders, via video from the conference, is proof positive that Francis is confident enough in the company’s future to be fully accessible and transparent.

Grab a coffee, sit back and watch this great interview. When you’re done, please feel free to post your comments and questions below for Francis to reply and comment.

North Bud Farms $NBUD.ca Announces Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

Posted by AGORACOM at 10:10 AM on Wednesday, October 17th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564639/hub/northbud_large.png

  • Acquires ownership of assets related to Janey’s line of cannabis accessories and IP related to product development.
  • Twelve Barrels Whiskey will receive 120,000 common shares of North Bud Farms at a deemed price of $0.40 per share for Janey’s rights
  • Announces Creation of “1017” Distribution

North Bud Farms Inc. (CSE: NBUD) (“NORTHBUD” or the “Company”) announces the creation of “1017” distribution and signing of a letter of intent to acquire Ontario cannabis store accessory distributor of Janey’s which operates as a subsidiary of Twelve Barrels Whiskey.

This Agreement provides that NORTHBUD will acquire ownership of assets related to Janey’s line of cannabis accessories and IP related to product development.

In exchange for these rights, Twelve Barrels Whiskey will receive 120,000 common shares of North Bud Farms at a deemed price of $0.40 per share.

NORTHBUD will provide the required capital investments to develop the proposed line of Janey’s products and may enter into revenue sharing agreements.

The companies intend to negotiate a definitive agreement within the next 30 days.

“This acquisition will provide a solid foundation for “1017” distribution,” said Ryan Brown, CEO and Founder of North Bud Farms Inc. “Janey’s brand was created as a platform for cannabis product development and distribution.”

Brown further stated, “With the acquisition of Janey’s brand NORTHBUD has secured an experienced product development and distribution partner with existing distribution into the Ontario Cannabis Store retail program.”

As per the terms of the Agreement, Cole Miller founder and sole owner of Janey’s brand and Twelve Barrels Whiskey will join the NORTHBUD team as product development manager.

“We are excited to have Cole lead this new division for both accessories and consumer product goods to be sold under our “1017” brand,” said Ryan Brown, CEO and Founder of North Bud Farms Inc.

“Our alcoholic beverages experience combined with NORTHBUD’s cannabis expertise and technology will allow our existing accessories brand to develop new products and expand into markets both domestically and abroad,” said Cole Miller, Founder of Janey’s.

Miller stated, “We are looking forward to working with NORTHBUD to further develop our line of cannabis-based beverages which are at a late stage in their development. As 1 of 10 accessories supplier to the Ontario Cannabis Store, we are well positioned to expand our product offering and gather consumer market data.”

About “1017” Brands

“1017” Brands has been established as a development and distribution platform for cannabis products and accessories. NORTHBUD intends to develop multiple products over a variety of product segments under the “1017” brand.

In August 2018 NORTHBUD successfully filed a trademark application for the use of the words and numbers “1017” as it relates to the global cannabis industry. The filing of this trademark gives NORTHBUD priority over the use of “1017” which we believe will become an iconic symbol in the Canadian cannabis industry.

“Branding will play an important role in establishing both product and company identity,” said Ryan Brown, CEO and Founder of North Bud Farms Inc. “October 17, 2018 represents a historic day in the history of Cannabis in Canada and NORTHBUD is proud to be able to carry that moniker moving forward. Over the next 12 months NORTHBUD intends to develop multiple consumer products to be sold under the “1017” brand.”

About Janey’s Inc.
Janey’s Inc. is a subsidiary of Twelve Barrels Whiskey Inc., an Ontario corporation. Janey’s is one of six approved Cannabis accessory suppliers to the Ontario cannabis store.

For more information visit: https://twelvebarrels.com/

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR).   North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms’ final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

$PYO PyroGenesis Announces Completion of its Cutting-Edge Additive Manufacturing Metal Powder Production Facility

Posted by AGORACOM at 8:59 AM on Tuesday, October 16th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564601/hub/PYR_header_1.png

  • Completed its cutting-edge Additive Manufacturing (“AM”) metal powder production facility.
  • The state-of-the-art facility is strictly dedicated to the production of plasma atomized Ti-6Al-4V powders, primarily targeting the aerospace and biomedical industries
  • PyroGenesis is a quality supplier of Ti-6Al-4V powder for the AM industry

MONTREAL, Oct. 16, 2018 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops and manufactures plasma waste-to-energy systems and plasma torch systems, is pleased to announce today the completion of its cutting-edge Additive Manufacturing (“AM”) metal powder production facility

This state-of-the-art facility will be strictly dedicated to the production of plasma atomized Ti-6Al-4V powders, primarily targeting the aerospace and biomedical industries.

“We are very excited about having completed this milestone. It puts PyroGenesis squarely on the map as a quality supplier of Ti-6Al-4V powder for the AM industry,” said Mr. Massimo Dattilo, Vice President of PyroGenesis Additive. “In parallel, we are also investigating other materials which can be produced with our other reactors, currently in our main facility.”

This facility now (i) houses a new plasma-based atomization unit, incorporating some of the previously announced advances, (ii) inventory storage, and (iii) logistics operations. These Step 1 innovations have reduced capital cost significantly. Future innovations will, once completed, increase yield and production rates.

“This next logical step of incorporating some of the previously announced improvements into a cutting-edge facility is now complete,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “After investing over $2.5M into this facility, all that remains is to incorporate post treatment equipment for it to be a stand-alone facility.”

Of note, the facility is ISO 9001:2015 certified and is on track to be AS9100D (Aviation, Space, and Defense) certified by year-end. Upon receipt, PyroGenesis will then pursue ISO 13485 (Medical devices).

Separately, PyroGenesis Additive will be exhibiting at Formnext in Frankfurt, Germany between November 13th and 16th (Hall 3.1 Booth A72). Contact us to book an appointment, or meet with us there.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a TSX Venture 50® high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol:PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

$ZEN Tokyo Tech Research Confirms Ease of Conversion of Zenyatta’s Albany Graphite to Graphene $GRAT

Posted by AGORACOM at 8:36 AM on Tuesday, October 16th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564424/hub/ZENYATTA_HUB.jpg

  • Researchers in Japan have published findings in the Journal of Materials Science
  •  “the smaller the feed graphite particle, the easier to exfoliate”
  • The exfoliation productivity of graphite derived from Zenyatta’s unique Albany deposit in Northern Ontario performed up to 1500% better than the researchers’ reference

Thunder Bay, Ontario–(Newsfile Corp. – October 16, 2018) – Zenyatta Ventures Ltd. (TSXV: ZEN) (“Zenyatta” or “Company”) today reported that researchers in Japan have published findings in the Journal of Materials Science linking particle size to the ease of producing graphene from graphite through exfoliation — the smaller the feed graphite particle, the easier to exfoliate. The researchers further concluded that, due to the size of its flakes, the exfoliation productivity of graphite derived from Zenyatta’s unique Albany deposit in Northern Ontario performed up to 1500% better than the researchers’ reference flake graphite materials.

In a 2017 Zenyatta news release, Dr. Yoshihiko Arao, Assistant Professor in the Department of Chemical Engineering at Tokyo Tech, stated “Zenyatta’s high-purity graphite material was tested by our scientific team on mechanical conversion to graphene and discovered it converted much easier and with higher yields of graphene than our reference material. We have tested many types of natural graphite but found Zenyatta’s Albany Graphite material to have better exfoliation performance and produce better graphene particles than the reference material. We believe that this is an extraordinary, unique material and we would like to carry out further collaborative work with Zenyatta on graphene applications.”

The following significant test results are reported in the paper by Dr. Arao and Dr. Masatoshi Kubouchi at Tokyo Tech:

  1. The main conclusion of the paper was that the smaller the feed graphite particle, the easier it is to exfoliate thus indicating that the graphite particle size is quite an important variable for successful exfoliation.
    • Exfoliation productivity of smaller Albany Graphite flakes performs up to 1500% better than the larger reference flake graphite materials.
    • Albany Graphite particles reach a 2 µm particle size with a standard milling process, while the reference flake graphite material could not mill below a 3 µm particle size as the graphite tends to agglomerate together.
    • It is concluded that the fine crystalline nature of Albany Graphite contributes to the relatively easy milling characteristics. This can be attributed to the unusual geological mode of formation (a rapid crystallization igneous process) which accounts for the superior crystallinity and overall quality of the graphite mineralization found in this unique deposit.
  2. Graphene exfoliated from Albany graphite produced material with the highest aspect ratio with an average thickness of 2.0 nm indicative of graphene with 2.4 layers. Also, the optical absorbance of the Zenyatta graphene dispersion was 2-10 times better than the other 3 reference samples that were tested. This demonstrated that concentrated graphene dispersions can be easily produced from Albany Graphite. The resulting small and thin graphene dispersion is suitable for printable inks.

This paper confirms the reason for success on the Company’s many graphene research and product development initiatives, especially in composites. Tokyo Tech has established that Zenyatta’s Albany Graphite converts (exfoliates) easily to graphene, producing mono-layer to tri-layer material with excellent dispersion properties and is highly suitable for many graphene and graphene-oxide applications.

Mr. Peter Wood, P.Eng, P.Geo., President and COO of Zenyatta, is the “Qualified Person” for the purposes of National Instrument 43-101 and has reviewed, prepared and supervised the preparation of the technical information contained in this news release.

For further information:

Dr. Francis Dubé, Co-CEO & Head of Business Development and Technology
Tel: +1 (289) 821-2820
Email: [email protected]

About Zenyatta

Zenyatta’s Albany Graphite Project hosts a large and unique quality deposit of highly crystalline graphite. Independent labs in Japan, UK, Israel, USA and Canada have demonstrated that Zenyatta’s Albany Graphite/Naturally PureTM easily converts (exfoliates) to graphene using a variety of simple mechanical and chemical methods. The deposit is located in northern Ontario just 30km north of the Trans-Canada Highway, near the communities of Constance Lake First Nation and Hearst. Important nearby infrastructure include hydro-power, natural gas pipeline, a rail line 50 km away and an all-weather road just 10 km from the deposit.

To find out more on Zenyatta Ventures Ltd., please visit our website at www.zenyatta.ca. A copy of this press release and all material documents with respect of the Company may be obtained on Zenyatta’s SEDAR profile at www.sedar.ca.

$APPB Applied BioSciences Launches Expanded Pet Line Under Herbal Pet $HTIM

Posted by AGORACOM at 11:56 AM on Tuesday, October 9th, 2018

 

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Expanded and launched a hemp derived CBD pet line under the Herbal Pet brand
  • In addition to CBD, the chews contain several important ingredients that promote good health.
  • Applied BioSciences continues to be at the forefront of the cannabinoid market, using organically grown plants, without pesticides or herbicides
  • The products will be sold on Herbal Pet’s new website (http://www.herbalpet.com)

Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has expanded and launched a hemp derived CBD pet line under the Herbal Pet brand. The products will be sold on Herbal Pet’s new website (http://www.herbalpet.com) and in select locations in the U.S.

Although the health benefits of CBD are now considered well known, one of the challenges of working with CBD is its bitter after taste. Applied Biosciences focused on this common feedback from humans and developed formulations to improve the experience for both humans and pets. Aromas from CBD are strong and to a dog, that level of concentration can be displeasing. To overcome this issue, the product line (including our chews) has been specifically formulated with natural, high protein, human grade chicken meat – our number 1 ingredient.

In addition to CBD, these chews contain several important ingredients that promote good health. The calming support chew consists of super foods (sweet potato and turmeric) as well as antioxidants (organic chamomile) and a natural amino acid (L-Theanine). The mobility support chew also has bone broth, glucosamine, and chondroitin for bone health. It is also grain-free. Importantly, these products contain no synthetic preservatives, no fillers, no Genetically Engineered ingredients (GMO) and no animal feed ingredients.

“Applied BioSciences continues to be at the forefront of the cannabinoid market, first using organically grown plants, without pesticides or herbicides as our main ingredient and now quickly and easily providing consumers with a variety of tinctures, topical creams and alternatives to the growing demand of this space. Our company continues to launch our product lines in select specialty and retail stores, people and pet owners will also be able to visit our websites to find holistic health and wellness alternatives that best suit their lifestyle,” commented Chris Bridges, President of Applied BioSciences Corp.

Applied BioSciences products are USDA-NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC- free. Our products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.

About Applied BioSciences Corp.
Applied BioSciences Corp. (http://www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact
Email: ir(at)appliedbiocorp.com or info(at)appliedbiocorp.com

To be added to the Applied BioSciences email distribution list, please email info(at)appliedbiocorp.com with APPB in the subject line.

Official Website:
http://www.appliedbiocorp.com

Brands:
http://www.remedishop.com http://www.herbalpet.com http://www.canagel.com

Follow us:
Facebook @remediplus & @HerbalPetMeds Instagram @remediplus & @herbal_pet Twitter @remediplus & @herbal_pet

 

$AAO.ca $IEQ.ca IntellaEquity (formerly Augusta Industries Inc.) to Commence Trading on the Canadian Securities Exchange October 4

Posted by AGORACOM at 9:27 AM on Tuesday, October 2nd, 2018

http://www.intellaequity.com/wp-content/uploads/2018/09/LogoMakr_2YZJyG.png

  • The common shares will trade under the symbol ” IEQ” October 4th on the CSE
  • “The listing of the Corporation’s common shares through the facilities of the CSE will allow the Corporation to carry out its objectives as a merchant bank,” stated Allen Lone, Chief Executive Officer of the Corporation.
  • “The cost effectiveness of a CSE listing will allow the Corporation to conserve its cash and deploy it to execute on proposed acquisitions.”

Toronto, Ontario–(Newsfile Corp. – October 2, 2018) – IntellaEquity Inc. (formerly Augusta Industries Inc.) (the “Corporation”) is pleased to announce that on the opening of the market on October 4, 2018, the Corporation’s common shares will commence trading through the facilities of the Canadian Securities Exchange (“CSE”). The common shares will trade under the symbol ” IEQ”.

The Corporation is also pleased to announce that it has completed the sale of its wholly owned subsidiary, Fox-Tek Canada Inc. to Mooncor Oil & Gas Corp. (“Mooncor”) for an aggregate purchase price of $21.5 million (the “Purchase Price”). The sale of Fox-Tek was approved by a majority of the minority shareholders at the annual and special shareholders’ meeting held on July 11, 2018.

$9,500,000 of the Purchase Price will be satisfied through the issuance of an aggregate of 47,500,000 post-consolidated common shares (the “Consideration Shares”) in the capital of Mooncor at a price of $0.20 per Consideration Share. The balance of the Purchase Price, being up to $12,000,000, will be satisfied through a royalty of 15% on all future sales of Fox-Tek’s products and a 20% royalty on all future sales of Fox-Tek’s services (collectively, the “Royalty”). The Royalty shall be payable until the earlier of (i) the 10 year anniversary of the closing of the acquisition of Fox-Tek, and (ii) the aggregate payment of $12 million.

In addition, the Corporation will continue its operations as a diversified investment and merchant banking firm focused on public companies and commodities. The Corporation’s proposed investment activities will include (i) public companies, (ii) near public companies and private capital, (iii) global venture capital initiatives and (iv) strategic physical commodities. However, the Corporation may take advantage of special situations and merchant banking opportunities, as such opportunities arise, and make investments in other sectors which the Corporation identifies from time to time as offering particular value.

In connection with the sale of Fox-Tek and its change of business, the Corporation changed its name from Augusta Industries Inc. to IntellaEquity Inc. and consolidated its issued and outstanding securities on the basis on ten pre-consolidated common shares for every one (1) post-consolidated common shares.

“The listing of the Corporation’s common shares through the facilities of the CSE will allow the Corporation to carry out its objectives as a merchant bank,” stated Allen Lone, Chief Executive Officer of the Corporation. “The cost effectiveness of a CSE listing will allow the Corporation to conserve its cash and deploy it to execute on proposed acquisitions.”

About the Corporation:

IntellaEquity is a publicly traded Canadian based venture capital firm focused on opportunistic investments in companies in the industrial, artificial intelligence and blockchain sectors. The Corporation seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Corporation’s ecosystem.

Corporation contact:

Allen Lone, President, CEO,
IntellaEquity Inc.
Tel: (905) 275-8111 Ext 226, email: [email protected]

$GR.ca Great Atlantic Exploration Update on Its Kagoot Brook Cobalt Project $ANX.ca $MOZ.ca $LAB.ca

Posted by AGORACOM at 8:49 AM on Tuesday, September 25th, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564603/hub/GREATATLANTIC_LOGO_TESTER-e1480712241913.jpg

  • Historical work at Kagoot Brook has delineated two drainages, two kilometres apart, that exhibit remarkably high cobalt values up to 6,000 ppm in the silts
  • Recent silt sampling results has fully corroborated the existence and intensity of the cobalt mineralization
  • Significant occurrence of manganese and base metals (nickel, copper, lead and zinc) with the cobalt mineralization.

Vancouver, British Columbia (FSCwire)GREAT ATLANTIC RESOURCES CORP. (TSX.V: GR) (the “Company” or “Great Atlantic”) is pleased to provide this update in regard to its Kagoot Brook Cobalt project.

To view the graphic in its original size, please click here

Kagoot Brook Co-Mn-Base Metal Project, New Brunswick Historical work at Kagoot Brook has delineated two drainages, two kilometres apart, that exhibit remarkably high cobalt values up to 6,000 ppm in the silts (see Company news releases dated May 31 and February 14, 2018).  The recent results from a complementary silt sampling program has:

1)            Fully corroborated the existence and intensity of the cobalt mineralization; and

2)            Revealed a strong relationship and significant occurrence of manganese and base metals (nickel, copper, lead and zinc) with the cobalt mineralization.

The observed suite of elements and local geological units supports a ferromanganese marine environment indicating a strong affinity and trap for cobalt and base metals; a setting similar to the well-known ferromanganese stratiform mineralizing models around the world.

Of note:

1.  The amount of manganese and iron in the cobalt enriched silts, upwards to 4.1% and 26.7% respectively, indicates a prevalent source with size potential; and

2.  The relative percentage of the manganese to cobalt indicates a favourable high cobalt tenor (i.e. grade component).

As a result, Great Atlantic’s optionee has initiated a follow-up stream silt sampling program with tightly spaced sample stations to better frame the contact of the underlying target mineralized horizon.  In conjunction, a detailed magnetometer and very low frequency electromagnetic (“VLF-EM”) survey has been initiated to map the underlying stratigraphy to assist with the targeting.

Once these additional surveys have been completed and integrated with the historical work, a drill program is planned.

No drilling has ever been conducted and no source of the historic geochemical anomalies is known on the property.

Note(*): The surface rock grab and stream silt samples reported in this release are solely designed to show the presence or absence of mineralization and to characterize the mineralization.  Grab and silt samples are by definition selective and not intended to provide nor should be construed as a representative indication of grade or mineralization at the projects.

Option Agreement

The Kagoot Brook property is 100% owned by Great Atlantic and is subject to an underlying agreement with a Explorex Resources Inc. ( EX.v ).  Explorex is acquiring up to a 75% interest in the project. (See News Release dated February 14,2018)

Technical Information in this news release has been reviewed by David Martin, P Geo., a Qualified Person as that term is defined in NI 43-101.

On Behalf of the board of director

“Christopher R Anderson”

Mr. Christopher R. Anderson ” Always be positive, strive for solutions, and never give up ”

President CEO Director

604-488-3900 – Dir

Investor Relations:

Kaye Wynn Consulting Inc.: 604-558-2630, Toll Free: 888-280-8128

E-mail: [email protected]

 

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Cobalt, Zinc, Tungsten and Gold.